CLINICAL_TRIALS
trial_result
· 2009-08-26
Clinical Trial Update: A Study Comparing Rapid Acting Intramuscular Olanzapine and Placebo in Agitated Patients With Schizophrenia [Phase 3]
Summary
Phase 3 study comparing rapid-acting intramuscular olanzapine to placebo in agitated patients with schizophrenia; results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Eli Lilly and Company | Conditions: Schizophrenia | Phase 3 | Status: COMPLETED | Results posted: 2009-08-26